Details of the Drug

General Information of Drug (ID: DMW8X05)

Drug Name
THR-149
Indication
Disease Entry ICD 11 Status REF
Diabetic macular edema 9B71.02 Phase 2 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
DA8W3Q

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasma kallikrein (KLKB1) TTMF8H9 KLKB1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04527107) A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema (KALAHARI). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Oxurion.